Home / Market Reports / Medical Care
/ Global Bone Mineral Testing Market Growth (Status and Outlook) 2024-2030
Global Bone Mineral Testing Market Growth (Status and Outlook) 2024-2030
-
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
The global Bone Mineral Testing market size is predicted to grow from US$ 1006 million in 2024 to US$ 1769 million in 2030; it is expected to grow at a CAGR of 9.9% from 2024 to 2030.
Bone Mineral Testing refers to diagnostic testing for bone metabolism markers of blood markers . These tests are crucial for assessing the risk of bone diseases, such as osteoporosis, which is characterized by low bone mass and increased fracture risk. Bone mineral testing is often used to diagnose, monitor, and evaluate bone health in patients, especially postmenopausal women, older adults, and individuals with risk factors for bone loss.
The bone mineral testing market is growing rapidly, driven by the following factors: aging population, increasing awareness of bone health, and growing demand for precision medicine and personalized treatment. With technological advances and changes in consumer demand, the market for bone marker testing kits has shown strong growth potential.
Although the attention paid to bone health has increased, bone marker detection kits are still in the promotion stage, and many potential users are not aware of the technology, especially in developing countries and regions. How to increase market awareness and promote popularization and application is an important challenge.
From a regional perspective, North America, especially the United States, is one of the main markets for the bone mineral testing market. The region has a large aging population and a large demand for early diagnosis of osteoporosis, and the market demand continues to grow.
With the improvement of medical conditions and the increase of health awareness, the market prospects in the Asia-Pacific region are very broad.
Common bone markers include bone formation markers such as P1NP, CTX, TRACP-5b, BAP, etc. Among them, P1NP accounts for the largest proportion, reaching 39% in 2023.
The global key manufacturers of bone mineral testing include Roche, BioMerieux, Immunodiagnostic Systems (IDS), Bio-Rad Laboratories, DiaSorin, Immundiagnostik, QuidelOrtho and Snibe, etc. In 2023, in term of revenue of bone mineral testing, the top five companies hold a share nearly 56%.
With the advancement of technology, bone mineral testing may develop towards intelligence and portability. For example, the application of mobile devices and portable testing equipment can make it more convenient for patients to undergo testing, especially in remote areas.
LPI (LP Information)' newest research report, the “Bone Mineral Testing Industry Forecast” looks at past sales and reviews total world Bone Mineral Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Bone Mineral Testing sales for 2024 through 2030. With Bone Mineral Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bone Mineral Testing industry.
This Insight Report provides a comprehensive analysis of the global Bone Mineral Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bone Mineral Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bone Mineral Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bone Mineral Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bone Mineral Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Bone Mineral Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Bone Metabolism Testing
Bone Formation Testing
Others
Segmentation by Application:
Hospital
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
BioMerieux
Immunodiagnostic Systems (IDS)
Bio-Rad Laboratories
DiaSorin
Immundiagnostik
QuidelOrtho
Snibe
Takara Bio
Aidian
Phicon
Biomedica
Novus Biologicals
Eagle Biosciences
Krishgen